PA
CAH icon

PharVision Advisers’s Cardinal Health CAH Stock Holding History

PharVision Advisers’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,367
Closed -$486K – 178
2025
Q4 		$486K Buy
2,367
+868
+58% +$163K 0.25% 44
2025
Q3 		$235K Sell
1,499
-195
-12% -$30.1K 0.13% 374
2025
Q2 		$285K Buy
+1,694
New +$251K 0.41% 91
2025
Q1 		– Sell
-2,000
Closed -$237K – 299
2024
Q4 		$237K Buy
+2,000
New +$233K 0.2% 239

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's CAH Position: Q1 2026 in Review

PharVision Advisers sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 2,367 shares — an estimated $486K sold.

PharVision Advisers first reported a position in CAH in Q4 2024 and held it in 4 quarters. The position peaked at $486K in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • PharVision Advisers reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 2,367 Cardinal Health shares in Q1 2026, an estimated $486K.
  • PharVision Advisers first reported a position in Cardinal Health in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Cardinal Health position peaked at $486K in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.